/
Metabolic & Endocrine
418Diseases↗
1.5KPipeline Programs↗
2.3KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
9,422
clinical trials
Completed5,582 · 59%
Recruiting1,169 · 12%
Unknown status680 · 7%
Not yet recruiting578 · 6%
Terminated535 · 6%
Active, not recruiting492 · 5%
Other386 · 4%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
39programs
28programs
27programs
25programs
22programs
Landscape
Diseases
Diabetes
Most programs19
Programs
1,090
Trials
35
Recruiting
Pre
11
P1
4
P2
3
P3
1
Appr
4
Most programs:
Eli Lilly
Eli LillyType 2 Diabetes
Most trials203
Programs
543
Trials
112
Recruiting
Pre
70
P1
7
P2
6
P3
35
Appr
52
Most programs:
Novo Nordisk
Novo NordiskDiabetes Mellitus
Highest activity368
Programs
266
Trials
35
Recruiting
Pre
37
P1
—
P2
5
P3
9
Appr
61
Most programs:
Novartis
NovartisType 2 Diabetes Mellitus
278 programs481 trialsApproved
Type 1 Diabetes
894 programs231 trialsApproved
Type 1 Diabetes Mellitus
528 programs210 trialsApproved
Diabetic Foot
39 programs76 trialsApproved
Overweight or Obesity
1 program104 trialsPhase 1
Insulin Resistance
151 programs38 trialsApproved
Polycystic Ovary Syndrome
346 programs40 trialsApproved
Metabolic Syndrome
136 programs50 trialsApproved
Obesity or Overweight
42 programs82 trialsPhase 3
Hypercholesterolemia
124 programs51 trialsApproved
Gestational Diabetes
319 programs53 trialsApproved
Diabetic Foot Ulcer
36 programs56 trialsPhase 2
Non-Alcoholic Steatohepatitis
110 programs46 trialsApproved
Adrenal
21 program47 trialsPhase 2
Familial Hypercholesterolemia
13 programs30 trialsApproved
Diabetic Foot Ulcers
0 programs43 trials
PCOS
4 programs38 trialsPreclinical
Overweight or Obese
11 program39 trialsPhase 2
Polycystic Ovary
0 programs40 trials
Morbid Obesity
530 programs9 trialsApproved
Hypoglycemia
120 programs19 trialsApproved
Hypothyroidism
12 programs24 trialsApproved
Hyperlipidemia
216 programs19 trialsApproved
Dyslipidemia
7 programs28 trialsApproved
NASH
2 programs33 trialsPhase 2
Thyroidectomy
20 programs33 trials
Hypertriglyceridemia
112 programs19 trialsApproved
Showing top 30 diseases by activity. 388 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)